as 05-20-2024 11:35am EST
Fresenius Medical Care is the largest dialysis company in the world, treating about 345,000 patients from over 4,100 clinics across the globe as of December 2022. In addition to providing dialysis services, the firm is a leading supplier of dialysis products, including machines, dialyzers, and concentrates. Fresenius accounts for about 35% of the global dialysis products market and benefits from being the world's only fully integrated dialysis business. Services account for roughly 80% of firmwide revenue, including care coordination and ancillary operations, while products account for the other roughly 20%. Products typically enjoy a higher margin, making them a strong contributor to the bottom line.
Founded: | N/A | Country: | Germany |
Employees: | N/A | City: | N/A |
Market Cap: | 13.1B | IPO Year: | 1996 |
Target Price: | $24.00 | AVG Volume (30 days): | 462.4K |
Analyst Decision: | Hold | Number of Analysts: | 2 |
Dividend Yield: | 2.89% | Dividend Payout Frequency: | Annual |
EPS: | 0.90 | EPS Growth: | -19.51 |
52 Week Low/High: | $16.37 - $27.72 | Next Earning Date: | 05-07-2024 |
Revenue: | $21,167,305,435 | Revenue Growth: | -0.41% |
Revenue Growth (this year): | 2.56% | Revenue Growth (next year): | 3.93% |
FMS Breaking Stock News: Dive into FMS Ticker-Specific Updates for Smart Investing
PR Newswire
4 days ago
Reuters
9 days ago
Simply Wall St.
11 days ago
Insider Monkey
12 days ago
Zacks
12 days ago
Reuters
12 days ago
Simply Wall St.
12 days ago
MT Newswires
13 days ago